Moderna mFLUSIVA Gets FDA Approval for Adults 50+
mFLUSIVA Article Preview The US Food and Drug Administration approved Moderna’s mFLUSIVA on August 5, 2026, for adults aged 50 and older, making it the first mRNA-based seasonal influenza vaccine…
Read, Learn & Express – Discover the World with Swikblog